Chemoinformaics analysis of Clausantalene
Molecular Weight | 238.371 | nRot | 3 |
Heavy Atom Molecular Weight | 212.163 | nRig | 9 |
Exact Molecular Weight | 238.193 | nRing | 2 |
Solubility: LogS | -4.336 | nHRing | 0 |
Solubility: LogP | 2.96 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 43.9906 |
nHD | 2 | BPOL | 26.0834 |
QED | 0.742 |
Synth | 5.29 |
Natural Product Likeliness | 2.145 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.004 |
HIA | 0.01 |
CACO-2 | -4.469 |
MDCK | 0.0000277 |
BBB | 0.893 |
PPB | 0.831782 |
VDSS | 1.136 |
FU | 0.129181 |
CYP1A2-inh | 0.124 |
CYP1A2-sub | 0.413 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.808 |
CYP2c9-inh | 0.057 |
CYP2c9-sub | 0.869 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.439 |
CYP3a4-inh | 0.036 |
CYP3a4-sub | 0.181 |
CL | 8.406 |
T12 | 0.345 |
hERG | 0.032 |
Ames | 0.005 |
ROA | 0.152 |
SkinSen | 0.752 |
Carcinogencity | 0.031 |
EI | 0.958 |
Respiratory | 0.736 |
NR-Aromatase | 0.03 |
Antiviral | Yes |
Prediction | 0.87273 |